Karabulut Ahmet, Gorgulu Sevket, Kocagoz Tanıl
Department of Cardiology, Acibadem Mehmet Ali Aydınlar University School of Medicine, Acibadem Atakent Hospital,Turgut Ozal Bulvarı, No: 16, 34303, Istanbul, Turkey.
Department of Medical Biotechnology, Acibadem Mehmet Ali Aydınlar University School of Medicine, Istanbul, Turkey.
Egypt Heart J. 2020 Nov 7;72(1):78. doi: 10.1186/s43044-020-00115-8.
Procedures for coronary chronic total occlusion (CTO) are still a clinical challenge with relatively lower success rates. Recent advances in the biotechnology and introduction of CTO-dedicated guidewires have increased the procedural success rate of CTO interventions. Herein, we aimed to reveal the clinical and angiographic predictors of the crossability of the initial guidewire choice and rational guidewire usage in CTO interventions. A total of 177 patients with an indication for a coronary CTO procedure were included in this study. The use of 1-3 guidewires and crossing of the CTO lesion with the initial guidewire choice was defined as rational guidewire usage. The CTO lesions were classified according to the Japanese chronic total occlusion registry (J-CTO) and EuroCTO scores for evaluating the difficulty of the procedures. Then, a statistical analysis was performed to assess the initial guidewire choice, crossability, and contributors to rational guidewire usage.
The mean J-CTO score was 1.42 ± 1.16, and the mean EuroCTO score was 1.44 ± 1.18. The success rate of the procedures was 90.4%. The initial guidewire choice crossed the lesion in 44.1% of the cases, in which 1-3 guidewires were used (82.1%). The crossability of the polymeric and moderate stiff tip guidewires was higher (82.1% and 64.1%, respectively), and the Pilot series was the most successful brand (36.2%). Logistic regression analysis confirmed that J-CTO score, procedural technique, guidewire type, and stiffness of the tip were the major predictors of rational guidewire usage.
Our analysis showed that the use of polymeric and moderate stiff tip guidewires, particularly the Pilot brand, were associated with rational guidewire usage in easy and intermediate difficulty CTO cases.
冠状动脉慢性完全闭塞(CTO)手术仍是一项临床挑战,成功率相对较低。生物技术的最新进展以及CTO专用导丝的引入提高了CTO介入手术的成功率。在此,我们旨在揭示CTO介入手术中初始导丝选择的可通过性以及合理使用导丝的临床和血管造影预测因素。本研究共纳入177例有冠状动脉CTO手术指征的患者。使用1 - 3根导丝并通过初始选择的导丝穿过CTO病变被定义为合理使用导丝。根据日本慢性完全闭塞登记系统(J - CTO)和欧洲CTO评分对CTO病变进行分类,以评估手术难度。然后进行统计分析,以评估初始导丝选择、可通过性以及合理使用导丝的影响因素。
J - CTO评分的平均值为1.42±1.16,欧洲CTO评分的平均值为1.44±1.18。手术成功率为90.4%。初始导丝选择在44.1%的病例中穿过了病变,其中使用了1 - 3根导丝(82.1%)。聚合物材质和中等硬度尖端导丝的可通过性更高(分别为82.1%和64.1%),Pilot系列是最成功的品牌(36.2%)。逻辑回归分析证实,J - CTO评分、手术技术、导丝类型和尖端硬度是合理使用导丝的主要预测因素。
我们的分析表明,在难度为简单和中等的CTO病例中,使用聚合物材质和中等硬度尖端导丝,尤其是Pilot品牌,与合理使用导丝相关。